Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,156.40
(
-0.18%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.20
(
4.63%
)
Bitcoin
78,292.22
(
0.07%
)
News Focus
News Focus
Post# of 197923
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CatfishHunter

Send PM Follow Ignore
Followers 68
Posts 9400
Boards Moderated 0
Alias Born 04/05/2016

CatfishHunter

Member Level

Re: Musical Shares post# 192194

Monday, 08/18/2025 12:24:52 PM

Monday, August 18, 2025 12:24:52 PM

Post# of 197923
OncoGel -  DOA

- OncoGel- Clinical trials (e.g., esophageal cancer) showed local paclitaxel release but no significant impact on overall tumor response, leading to study termination in some cases.- OncoGel: Developed by MacroMed Inc. and Boston Scientific Corporation, with clinical trials conducted in the late 2000s to early 2010s. No current activity suggests discontinuation or shift in focus.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RDGL News
More RDGL News